Price Alert

OncoCyte Corporation (OCX)

NASDAQ: OCX · Real-Time Price · USD

3.20

0.47 (17.22%)

At close: Jun 17, 2025, 3:59 PM

OncoCyte Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	31.03M	8.64M	3.36M	9.26M	5.58M	9.43M	13.78M	17.37M	11.8M	19.99M	32.05M	44.84M	20.41M	35.6M	43.34M	46.47M	58.91M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	441K	530K	553K	433K	419K	579K	574K	904K	923K	1.06M	887K
Long-Term Investments	n/a	n/a	n/a	n/a	1.7M	1.7M	1.7M	1.7M	1.7M	n/a	1.7M	1.7M	1.7M	1.7M	1.7M	1.7M	1.7M
Other Long-Term Assets	2.34M	5.96M	5.89M	2.26M	438K	463K	2.22M	-5.86M	2.07M	2.07M	2.07M	2.08M	2M	1.96M	1.96M	2.09M	2.04M
Receivables	3.54M	1.61M	209K	85K	161K	484K	1.88M	1.72M	1.9M	2.01M	1.99M	1.8M	2.12M	1.44M	1.03M	1.02M	703K
Inventory	459K	410K	232K	n/a	n/a	n/a	139K	191K	421K	2.12M	n/a	n/a	n/a	304K	n/a	2.00	2.32M
Other Current Assets	1.24M	1.1M	989K	627K	796K	782K	811K	1.37M	1.39M	3.1M	2.17M	2.15M	1.51M	450K	2.3M	1.44M	985K
Total Current Assets	36.26M	11.76M	4.79M	9.97M	6.54M	10.7M	16.92M	20.98M	15.65M	25.54M	36.64M	49.37M	24.62M	39.14M	47.59M	49.99M	62.82M
Property-Plant & Equipment	7.16M	2.76M	3M	5.94M	5.73M	5.44M	5.83M	7.89M	8.42M	10.85M	11.59M	11.58M	10.65M	8.53M	7.64M	7.34M	7.27M
Goodwill & Intangibles	14.6M	14.61M	56.53M	56.55M	56.57M	56.59M	56.62M	56.64M	56.66M	61.63M	107.05M	108.03M	109M	109.93M	111.15M	117.95M	57.18M
Total Long-Term Assets	24.1M	23.32M	65.42M	64.75M	64.44M	64.19M	64.67M	58.67M	67.15M	74.56M	120.71M	121.68M	121.65M	120.42M	120.75M	127.39M	66.48M
Total Assets	60.36M	35.08M	70.22M	74.72M	70.97M	74.89M	81.59M	87.54M	82.8M	100.09M	157.34M	171.05M	146.27M	159.56M	168.34M	177.38M	129.31M
Account Payables	2.28M	2.28M	872K	1.05M	908K	953K	1.14M	875K	1.4M	1.25M	1.83M	2.46M	2.58M	1.81M	1.2M	1.09M	1.09M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	6.09M	-737K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	1.29M	n/a	n/a	n/a	665K	720K	737K	775K	n/a	827K	574K	1.79M	2.13M	2.29M	2.24M	3.33M
Other Current Liabilities	2.96M	2.17M	6.93M	3.81M	2.31M	3.34M	3.41M	4.02M	4.26M	4.43M	5.55M	2.92M	5.35M	5.98M	5.77M	11M	2.07M
Total Current Liabilities	9.68M	7.28M	9.09M	7.2M	8.33M	7.19M	8.03M	7.67M	9.43M	12.11M	12.95M	14.15M	13.96M	14.12M	13.38M	19.77M	9.69M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	178K	541K	951K
Other Long-Term Liabilities	38.38M	37.71M	48.71M	42.18M	43.21M	39.9M	33.64M	33.88M	32.89M	50.96M	64.6M	65.67M	72.03M	76.68M	51.67M	50.51M	8.18M
Total Long-Term Liabilities	40.46M	40.08M	51.41M	44.82M	45.73M	42.1M	35.99M	36.27M	35.44M	53.69M	67.53M	73.65M	75.35M	80.23M	55.62M	54.94M	12.99M
Total Liabilities	50.14M	47.35M	60.51M	52.02M	54.05M	49.3M	44.02M	43.94M	44.87M	65.8M	80.49M	87.81M	89.31M	94.35M	68.99M	74.72M	22.68M
Total Debt	3.48M	3.66M	3.99M	3.67M	3.33M	2.87M	3.07M	3.13M	3.33M	3.54M	3.76M	4.55M	5.12M	5.68M	6.23M	6.67M	8.14M
Common Stock	367.39M	338.24M	326.68M	326.2M	310.55M	310.3M	310M	309.54M	295.53M	294.93M	292.54M	289.65M	254.99M	252.95M	251.24M	240.75M	234.22M
Retained Earnings	-357.21M	-350.54M	-317.03M	-303.54M	-299M	-289.88M	-272.46M	-265.98M	-257.64M	-260.68M	-215.7M	-206.44M	-198.06M	-187.77M	-151.89M	-138.09M	-127.6M
Comprehensive Income	41K	21K	57K	37K	40K	49K	32K	41K	43K	39K	19K	31K	38K	37K	n/a	n/a	-1.68M
Shareholders Equity	10.22M	-12.27M	9.71M	22.7M	16.92M	25.59M	37.56M	43.6M	37.93M	34.29M	76.86M	83.24M	56.97M	65.22M	99.35M	102.67M	106.63M
Total Investments	n/a	n/a	n/a	1.7M	1.7M	1.7M	441K	530K	553K	433K	419K	579K	574K	904K	923K	1.06M	887K